The Pantheon group, active in the medical equipment sector for hospitals and diagnostic centres, announces the acquisition of 95,43% of Tbs, European leader in clinical engineering services, following the positive conclusion of the takeover bid launched on 26 June.
The membership period will reopen on July 20 and end on July 26. Tbs shareholders who have not yet delivered the shares will have the opportunity to accept the Offer at the same price of 2,2 euro per share with a premium of 29% compared to the weighted average price per share in the 12 months preceding the takeover bid announcement. The process of delisting Tbs shares from Aim trading will then proceed.
